Development of an anti-rat complement C2 antibody that improves renal outcome in a rat kidney transplant model
BackgroundPreviously we reported on the therapeutic monoclonal anti-human C2 antibody empasiprubart that inhibits activation of the classical and lectin pathways of complement. Preclinical studies with this antibody are hampered by its low affinity for…